A 2025 preliminary safety study administered intravenous BPC-157 to 2 participants at escalating doses with no adverse effects reported, but the extremely limited sample size prevents meaningful conclusions
Skipping Cycling Protocols The Problem: Continuous daily use without planned off-periods, assuming "more is better." Why It Matters: Prolonged use without breaks may lead to receptor desensitization, reduced effectiveness, and potential unknown long-term effects
siRNA-mediated knockdown of 12/15-LOX confers resistance to ferroptosis in vitro and protects neurons in ischemic mouse models (160)
Standard Protocol (Weeks 3-8) After the initial adaptation period, most individuals progress to the standard 5-amino-1MQ dosage of 75mg daily
We help our patients move from wellness to greatness, and live the happier, healthier, and more productive lives they deserve
Appetite suppression typically becomes noticeable within the first 1 to 2 weeks of dosing